DTIL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Precision BioSciences Inc (DTIL) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of significant positive catalysts, weak financial performance, and absence of proprietary trading signals suggest holding off on this stock until more favorable conditions arise.
The MACD is above 0 but contracting, indicating a neutral to slightly bullish trend. RSI is in the neutral zone at 53.28, showing no clear overbought or oversold conditions. Moving averages are converging, and the stock is trading near its pivot level of 3.94, with resistance at 4.129 and support at 3.751. Overall, the technical indicators do not suggest a strong buy signal.
NULL identified. No recent news, no significant hedge fund or insider activity, and no congress trading data.
The company's financial performance is weak, with a significant YoY revenue drop (-97.74%) and negative EPS (-1.84). The regular market price change is -2.68%, and there is no recent positive sentiment or trading momentum.
In Q3 2025, revenue dropped by -97.74% YoY to $13,000, while net income improved slightly to -$21.77M (+32.55% YoY). EPS decreased by -18.22% YoY to -1.84. Gross margin remained flat at 100%. Overall, the financials reflect poor growth trends.
No data available for trend analysis or analyst ratings.
